Cargando…

Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and Immunotypes

Identifying the targets of broadly neutralizing antibodies to HIV-1 and understanding how these antibodies develop remain important goals in the quest to rationally develop an HIV-1 vaccine. We previously identified a participant in the CAPRISA Acute Infection Cohort (CAP257) whose plasma neutralize...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wibmer, Constantinos Kurt, Bhiman, Jinal N., Gray, Elin S., Tumba, Nancy, Abdool Karim, Salim S., Williamson, Carolyn, Morris, Lynn, Moore, Penny L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814426/ https://www.ncbi.nlm.nih.gov/pubmed/24204277 http://dx.doi.org/10.1371/journal.ppat.1003738

Ejemplares similares

HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth
por: Sheward, Daniel J., et al.
Publicado: (2018)

Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope
por: Anthony, Colin, et al.
Publicado: (2017)

Limited Neutralizing Antibody Specificities Drive Neutralization Escape in Early HIV-1 Subtype C Infection
por: Moore, Penny L., et al.
Publicado: (2009)

Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
por: Lacerda, Miguel, et al.
Publicado: (2013)

Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies
por: Scheepers, Cathrine, et al.
Publicado: (2022)

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
por: Wibmer, Constantinos Kurt, et al.
Publicado: (2021)

Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development
por: Malherbe, Delphine C., et al.
Publicado: (2020)

Sequential exposure to specific antibody escape mutations may program neutralization breadth during subtype A HIV-1 infection
por: Murphy, MK, et al.
Publicado: (2012)

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
por: Cele, Sandile, et al.
Publicado: (2021)

Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape
por: Scheepers, Cathrine, et al.
Publicado: (2020)

A38 Diversity analyses of HIV-1 envelope glycoproteins in HIV-infected individuals with and without broadly neutralizing antibodies
por: Mabvakure, B., et al.
Publicado: (2017)

The breadth of HIV-1 neutralizing antibodies depends on the conservation of key sites in their epitopes
por: Bai, Hongjun, et al.
Publicado: (2019)

Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway
por: Mielke, Dieter, et al.
Publicado: (2019)

Escape of Hepatitis C Virus from Epitope I Neutralization Increases Sensitivity of Other Neutralization Epitopes
por: Gu, Jun, et al.
Publicado: (2018)

Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth
por: Murphy, Megan K., et al.
Publicado: (2013)

Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune System
por: Bhiman, Jinal N., et al.
Publicado: (2017)

Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth
por: Chukwuma, Valentine U., et al.
Publicado: (2018)

Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies
por: Bhiman, Jinal N., et al.
Publicado: (2015)

Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape
por: Wibmer, Constantinos Kurt, et al.
Publicado: (2017)

Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies
por: Mabvakure, Batsirai M., et al.
Publicado: (2019)

HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known Epitopes
por: Ditse, Zanele, et al.
Publicado: (2018)

HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing Antibodies
por: Sheward, Daniel J., et al.
Publicado: (2022)

Structure of an N276-Dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole Adjacent to the CD4 Binding Site
por: Wibmer, Constantinos Kurt, et al.
Publicado: (2016)

Somatic hypermutation to counter a globally rare viral immunotype drove off-track antibodies in the CAP256-VRC26 HIV-1 V2-directed bNAb lineage
por: Sacks, David, et al.
Publicado: (2019)

Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies
por: Muecksch, Frauke, et al.
Publicado: (2021)

Defining Breadth of Hepatitis C Virus Neutralization
por: Kinchen, Valerie J., et al.
Publicado: (2018)

Leveraging South African HIV research to define SARS‐CoV‐2 immunity triggered by sequential variants of concern
por: Bhiman, Jinal N., et al.
Publicado: (2022)

Fine epitope signature of antibody neutralization breadth at the HIV-1 envelope CD4-binding site
por: Cheng, Hao D., et al.
Publicado: (2018)

Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation
por: Johnson, Erik L., et al.
Publicado: (2018)

Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer
por: van Schooten, Jelle, et al.
Publicado: (2022)

Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
por: Muecksch, Frauke, et al.
Publicado: (2021)

SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodies
por: Moyo-Gwete, Thandeka, et al.
Publicado: (2021)

Affinity maturation pathway of an anti-MPER neutralizing mAb, CAP206-CH12
por: Tumba, NL, et al.
Publicado: (2012)

SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
por: Cele, Sandile, et al.
Publicado: (2021)

South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication
por: Richardson, Simone I, et al.
Publicado: (2015)

The epitope arrangement on flavivirus particles contributes to Mab C10’s extraordinary neutralization breadth across Zika and dengue viruses
por: Sharma, Arvind, et al.
Publicado: (2021)

The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
por: Xiong, Hualong, et al.
Publicado: (2022)

Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses
por: Jia, Janice Zhirong, et al.
Publicado: (2022)

Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
por: Khan, Khadija, et al.
Publicado: (2022)

Plasma IL-5 but Not CXCL13 Correlates With Neutralization Breadth in HIV-Infected Children
por: Roider, Julia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v106v14tqs03g9bcvo09rffbqt